Eurofins MWG Operon Signs Contract to Supply Oligonucleotides to Research Councils

Eurofins MWG Operon, international market leader and expert for custom oligonucleotide synthesis and RCUK Shared Services Centre Limited (RCUK SSC Ltd) have signed a three year contract for the supply of synthetic DNA & RNA oligonucleotides. This long term contract builds on the relationship developed as a preferred supplier to the Medical Research Council (MRC) during the previous four years.

RCUK SSC Ltd has been set up by the seven Research Councils of the UK (RCUK) to provide centralised services to the Research Councils and their institutes in; human resources (HR), finance, procurement, Information Technology, Information Systems and grants processing. By adopting a shared services approach, the Research Councils are making financial savings, and are at the same time increasing their operational efficiency.

"We are very proud that RCUK SSC Ltd has selected Eurofins MWG Operon as one of their service providers of choice, on behalf of the UK's Research Councils and continues our business relationship" says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services. "By signing the three year contract, RCUK SSC Ltd confirms their trust in our product quality and outstanding service with which Eurofins MWG Operon has identified itself for more than twenty years."

Richard Fowles, Category Manager with RCUK SSC Ltd commented, "We are very pleased to be able to announce Eurofins MWG Operon is to be one of our preferred suppliers of oligos. We feel that their great product offering will be of significant benefit to researchers."

Eurofins MWG Operon also provides best in class next generation sequencing services, Sanger sequencing, siRNA and gene synthesis services and is committed to continually optimizing and improving processes and product quality to ensure that they deliver their products and services in the fastest and most convenient manner possible.